# Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)

> **NCT00050622** · NA · COMPLETED · sponsor: **Florida International University** · enrollment: 154 (actual)

## Conditions studied

- Attention Deficit Disorder With Hyperactivity

## Interventions

- **DRUG:** Methylphenidate 0.15 mg/kg
- **BEHAVIORAL:** Low-Intensity BMOD
- **DRUG:** Methylphenidate 0.3 mg/kg
- **DRUG:** Placebo
- **DRUG:** Methylphenidate 0.6 mg/kg
- **BEHAVIORAL:** High Intensity BMOD

## Key facts

- **NCT ID:** NCT00050622
- **Lead sponsor:** Florida International University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** 2004-08
- **Final completion:** 2005-06
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2016-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00050622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00050622, "Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00050622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*